Gelesis Holdings Cash on Hand 2021-2022 | GLS
Gelesis Holdings cash on hand from 2021 to 2022. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Gelesis Holdings Annual Cash on Hand
(Millions of US $) |
| 2021 |
$0 |
| 2020 |
$0 |
| 2019 |
$ |
Gelesis Holdings Quarterly Cash on Hand
(Millions of US $) |
| 2022-03-31 |
$34 |
| 2021-12-31 |
$28 |
| 2021-09-30 |
$0 |
| 2021-06-30 |
$1 |
| 2021-03-31 |
$1 |
| 2020-12-31 |
|
| 2020-09-30 |
$1 |
| 2020-06-30 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.114B |
$0.011B |
|
Gelesis is a consumer-centered biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Gelesis, formerly known as Capstar Special Purpose Acquisition Corp., is based in BOSTON.
|
